Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Neuzil

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Circulation|May 18, 2023
Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF RegistryMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 1, 2022
Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)Emmanuel Ekanem, Vivek Y Reddy, Boris Schmidt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 17, 2025
Repeat Procedures After Pulsed Field Ablation for Atrial Fibrillation: MANIFEST-REDO StudyDaniel Scherr, Mohit K Turagam, Philippe Maury, et al.
JACC. Clinical Electrophysiology|March 2, 2024
Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial FibrillationMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
The New England Journal of Medicine|May 20, 2024
A Modular Communicative Leadless Pacing-Defibrillator SystemReinoud E Knops, Michael S Lloyd, Paul R Roberts, et al.
JACC. Clinical Electrophysiology|June 12, 2024
Safety and Effectiveness of Pulsed Field Ablation for Atrial Fibrillation in Patients With Heart FailureMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Circulation|May 18, 2023
Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF RegistryMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 1, 2022
Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)Emmanuel Ekanem, Vivek Y Reddy, Boris Schmidt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 17, 2025
Repeat Procedures After Pulsed Field Ablation for Atrial Fibrillation: MANIFEST-REDO StudyDaniel Scherr, Mohit K Turagam, Philippe Maury, et al.
JACC. Clinical Electrophysiology|March 2, 2024
Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial FibrillationMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
The New England Journal of Medicine|May 20, 2024
A Modular Communicative Leadless Pacing-Defibrillator SystemReinoud E Knops, Michael S Lloyd, Paul R Roberts, et al.
JACC. Clinical Electrophysiology|June 12, 2024
Safety and Effectiveness of Pulsed Field Ablation for Atrial Fibrillation in Patients With Heart FailureMohit K Turagam, Petr Neuzil, Boris Schmidt, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Pageof 27